HCV E1 comprising specific disulfide bridges
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 19, 2008
Grant Date -
Feb 16, 2006
app pub date -
Mar 8, 2005
filing date -
Mar 8, 2004
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention relates to recombinantly or synthetically produced HCV E1 envelope proteins or parts thereof comprising disulfides between specific cysteine residues. The invention further relates to viral-like particles and compositions comprising said HCV E1 envelope proteins or parts thereof as well as to methods using said HCV E1 envelope proteins or parts thereof, and to kits comprising said HCV E1 envelope proteins or parts thereof.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully